udt-logo-verdana-white-3
  • About us
  • Investment focus
  • Team
  • Investment proposal
  • contact
  • en
  • nl
AdobeStock_98985434
  1. Home›
  2. News

News.

Read the latest news here.

Category
  • News
  • Press
  • Case
  • Event
  • Article
  • Blog
  • Story
Market
  • Aerospace
  • Agri & Food
  • Defense & Security
  • Energy
  • High-tech systems & Materials
  • Life sciences & Health
  • Smart industries
  • Water & Maritime
Latest
  • Latest
  • Oldest
Expert_SeriousVR2Expert_SeriousVR2
Article

Expert Interview with Marjo Nieuwenhuijse from Serious VR

Read more
Expertinterview_Recreate3Expertinterview_Recreate3
Article

Expert Interview with Jeroen Schiphorst from Recreate Solutions on VR, AR and MR

Read more
suster-chemical-analysessuster-chemical-analyses
News

More fuel-efficient and less CO2 thanks to new absorption technology

Read more
IMG_0790IMG_0790
Case

How to Restart Group Training After a Long Break from Matches and Practice

As European football leagues face decisions on when to restart, coaches are grappling with how to optimally prepare their teams. Our guide provides practical advice for designing effective training schedules to get your players match-ready in just 2 to 4 weeks. Discover how to balance high-intensity drills, sport-specific exercises, and recovery periods to enhance performance and avoid injury. Whether your team has 2, 3, or 4 weeks before the competition resumes, follow these expert recommendations to ensure your players are fit and prepared for the challenges ahead.

Read more
Snelheidsmeter-in-middenSnelheidsmeter-in-midden
Blog

Even in technology, you need to tell stories

Read more
MedRingMedRing
Press

Demcon invests in LiGalli’s vaginal MdRing

MedRing by LiGalliMore effective drug delivery and better diagnostics for women Incontinence is an extremely annoying condition for which current treatment, in the form of pills, has many side effects. LiGalli has developed a unique vaginal ring that delivers controlled incontinence medicine in a liquid form, as a result, the woman experiences fewer side effects. LiGalli’s MedRing enables more effective drug delivery and better diagnostics, and is controlled via a smartphone app. In this way, incontinence can be treated in a targeted manner, so that women can go through their day with more control. Recently, technology developer and producer Demcon completed the development and first production of the MedRing on behalf of LiGalli. The partners are now working together on new versions of the MedRing, for the delivery of other medicines, and also for diagnostics. This week, LiGalli closed an investment round to finance the market launch of the first MedRing and the development of subsequent versions. In addition, LiGalli and Demcon have intensified their cooperation, as Demcon has also come on board as a new shareholder. “We want to build a Dutch company together”, says LiGalli CEO Willem de Laat, “and ensure that the benefits of our ring become available to as many women as possible.”

Read more
« ‹
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263
› »
Page 59 of 63
udt-logo-verdana-white-3
About usInvestment focusTeamInvestment proposal

Contact us

send a message
cookie policyprivacy statement
© 2026 UDT. All rights reserved.